Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Acrivon Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +6 vs. Q4 2023
- Shares held
- 15.2M
- −63.5K (−0.4%) vs. Q4 2023
- Total value
- $109.0M
- +$34.5M (+46.3%) vs. Q4 2023
- New holders
- 12
- 14 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 3 | $0 | 0.00% | +3 | New |
| Capital Advisors, Ltd. LLC | 48 | $0 | 0.00% | +48 | New |
| Avion Wealth | 88 | $1.00K | 0.00% | +88 | New |
| Russell Investments Group, Ltd. | 223 | $1.59K | 0.00% | +223 | New |
| Royal Bank of Canada | 278 | $2.00K | 0.00% | −2,210−88.8% | Reduced |
| Amalgamated Bank | 378 | $3.00K | 0.00% | −853−69.3% | Reduced |
| Ameritas Investment Partners, Inc. | 695 | $4.97K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 800 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 817 | $5.84K | 0.00% | −1,201−59.5% | Reduced |
| Legal & General Group Plc | 839 | $5.93K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,027 | $7.34K | 0.00% | +221+27.4% | Added |
| Catalyst Funds Management Pty Ltd | 1,044 | $7.46K | 0.00% | +1,044 | New |
| California State Teachers Retirement System | 1,227 | $8.77K | 0.00% | −204−14.3% | Reduced |
| New York State Common Retirement Fund | 2,273 | $16.3K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 4,299 | $30.7K | 0.00% | +1,608+59.8% | Added |
| Citigroup Inc | 4,536 | $32.4K | 0.00% | +2,489+121.6% | Added |
| JPMorgan Chase & Co | 4,959 | $35.5K | 0.00% | −28,384−85.1% | Reduced |
| Advisor Group Holdings, Inc. | 5,080 | $36.3K | 0.00% | +5,080 | New |
| American International Group, Inc. | 6,016 | $43.0K | 0.00% | +1,695+39.2% | Added |
| Bank of America Corp | 6,039 | $43.2K | 0.00% | −4,049−40.1% | Reduced |
| Raymond James & Associates | 10,200 | $72.9K | 0.00% | +10,200 | New |
| AAFCPAs Wealth Management, LLC | 10,678 | $76.3K | 0.04% | 00.0% | Unchanged |
| Rhumbline Advisers | 10,889 | $77.8K | 0.00% | +1,619+17.5% | Added |
| Nuveen Asset Management, LLC | 11,821 | $84.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 12,745 | $91.1K | 0.00% | +12,745 | New |
| Prelude Capital Management, LLC | 13,000 | $93.0K | 0.01% | +13,000 | New |
| Morgan Stanley | 17,243 | $123.3K | 0.00% | −8,388−32.7% | Reduced |
| Barclays PLC | 21,324 | $152.5K | 0.00% | −3,160−12.9% | Reduced |
| Bank of New York Mellon Corp | 24,413 | $174.6K | 0.00% | −382−1.5% | Reduced |
| Baker Bros. Advisors LP | 52,885 | $378.1K | 0.00% | +52,885 | New |
| Exchange Traded Concepts, LLC | 56,200 | $401.8K | 0.01% | +42,911+322.9% | Added |
| Bridgeway Capital Management, LLC | 58,181 | $416.0K | 0.01% | +26,200+81.9% | Added |
| Charles Schwab Investment Management Inc | 77,382 | $553.3K | 0.00% | +8,881+13.0% | Added |
| Millennium Management LLC | 95,497 | $682.8K | 0.00% | +95,497 | New |
| Renaissance Technologies LLC | 102,600 | $734.0K | 0.00% | +102,600 | New |
| Northern Trust Corp | 107,750 | $770.4K | 0.00% | +27,601+34.4% | Added |
| UBS Oconnor LLC | 126,949 | $907.7K | 0.03% | +33,506+35.9% | Added |
| DAFNA Capital Management LLC | 131,351 | $939.2K | 0.21% | 00.0% | Unchanged |
| State Street Corp | 133,276 | $952.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 242,846 | $1.74M | 0.00% | +53,646+28.4% | Added |
| Vanguard Group Inc | 507,185 | $3.63M | 0.00% | +31,208+6.6% | Added |
| Marshall Wace, LLP | 597,469 | $4.27M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 743,901 | $5.32M | 0.00% | +178,069+31.5% | Added |
| Wellington Management Group LLP | 888,130 | $6.35M | 0.00% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 1,652,605 | $11.8M | 2.85% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,680,027 | $12.0M | 0.01% | +30,368+1.8% | Added |
| Perceptive Advisors LLC | 3,007,858 | $21.5M | 0.38% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,810,508 | $34.4M | 0.44% | 00.0% | Unchanged |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −430,252−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −226,375−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −46,072−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −31,939−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −13,187−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −260−100.0% | Sold out |